Cutting Edge of Immune Response and Immunosuppressants in Allogeneic and Xenogeneic Islet Transplantation

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Sep 30

PMID 39346923

Authors

Liting Yue

Jisong Li

Mingjun Yao

Siyuan Song

Xiaoqin Zhang

Yi Wang

Affiliations

Soon will be listed here.

Abstract

As an effective treatment for diabetes, islet transplantation has garnered significant attention and research in recent years. However, immune rejection and the toxicity of immunosuppressive drugs remain critical factors influencing the success of islet transplantation. While immunosuppressants are essential in reducing immune rejection reactions and can significantly improve the survival rate of islet transplants, improper use of these drugs can markedly increase mortality rates following transplantation. Additionally, the current availability of islet organ donations fails to meet the demand for organ transplants, making xenotransplantation a crucial method for addressing organ shortages. This review will cover the following three aspects: 1) the immune responses occurring during allogeneic islet transplantation, including three stages: inflammation and IBMIR, allogeneic immune response, and autoimmune recurrence; 2) commonly used immunosuppressants in allogeneic islet transplantation, including calcineurin inhibitors (Cyclosporine A, Tacrolimus), mycophenolate mofetil, glucocorticoids, and Bortezomib; and 3) early and late immune responses in xenogeneic islet transplantation and the immune effects of triple therapy (ECDI-fixed donor spleen cells (ECDI-SP) + anti-CD20 + Sirolimus) on xenotransplantation.

References

Sarikonda G, Pettus J, Phatak S, Sachithanantham S, Miller J, Wesley J . CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J Autoimmun. 2014; 50:77-82. DOI: 10.1016/j.jaut.2013.12.003. View

Gu Y, Lindner J, Kumar A, Yuan W, Magnuson M . Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Diabetes. 2011; 60(3):827-37. PMC: 3046843. DOI: 10.2337/db10-1194. View

Yan L, Ye L, Chen Y, He S, Zhang C, Mao X . The Influence of Microenvironment on Survival of Intraportal Transplanted Islets. Front Immunol. 2022; 13:849580. PMC: 8995531. DOI: 10.3389/fimmu.2022.849580. View

van der Windt D, Echeverri G, IJzermans J, Cooper D . The Choice of Anatomical Site for Islet Transplantation. Cell Transplant. 2017; 17(9):1005-1014. DOI: 10.3727/096368908786991515. View

Weber M, Prodhomme T, Patarroyo J, Molnarfi N, Karnezis T, Lehmann-Horn K . B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol. 2010; 68(3):369-83. PMC: 3375897. DOI: 10.1002/ana.22081. View

Xie J, Herbert T . The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes. Cell Mol Life Sci. 2011; 69(8):1289-304. PMC: 11114779. DOI: 10.1007/s00018-011-0874-4. View

Allison A, Eugui E . Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation. Transplant Proc. 1994; 26(6):3205-10. View

Singh N, Guo L, Mhoyan A, Shirwan H . Predominant expression of Th2 cytokines and interferon-gamma in xenogeneic cardiac grafts undergoing acute vascular rejection. Transplantation. 2003; 75(5):586-90. DOI: 10.1097/01.TP.0000052594.83318.68. View

Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A . Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007; 357(25):2562-75. DOI: 10.1056/NEJMoa067411. View

10.

Chen Q, Liu L, Zhao X, Liang J, Li S . Challenges and opportunities in the islet transplantation microenvironment: a comprehensive summary of inflammatory cytokine, immune cells, and vascular endothelial cells. Front Immunol. 2023; 14:1293762. PMC: 10725940. DOI: 10.3389/fimmu.2023.1293762. View

11.

Allison A, Hovi T, Watts R, Webster A . The role of de novo purine synthesis in lymphocyte transformation. Ciba Found Symp. 1977; (48):207-24. DOI: 10.1002/9780470720301.ch13. View

12.

Eisenbarth G . Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986; 314(21):1360-8. DOI: 10.1056/NEJM198605223142106. View

13.

Getts D, Turley D, Smith C, Harp C, McCarthy D, Feeney E . Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. J Immunol. 2011; 187(5):2405-17. PMC: 3159828. DOI: 10.4049/jimmunol.1004175. View

14.

Pareta R, McQuilling J, Sittadjody S, Jenkins R, Bowden S, Orlando G . Long-term function of islets encapsulated in a redesigned alginate microcapsule construct in omentum pouches of immune-competent diabetic rats. Pancreas. 2014; 43(4):605-13. PMC: 3981909. DOI: 10.1097/MPA.0000000000000107. View

15.

Matsumoto S, Tan P, Baker J, Durbin K, Tomiya M, Azuma K . Clinical porcine islet xenotransplantation under comprehensive regulation. Transplant Proc. 2014; 46(6):1992-5. DOI: 10.1016/j.transproceed.2014.06.008. View

16.

Hutchings P, Rosen H, OReilly L, Simpson E, Gordon S, Cooke A . Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature. 1990; 348(6302):639-42. DOI: 10.1038/348639a0. View

17.

. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group. Transplantation. 2001; 71(8):1091-7. DOI: 10.1097/00007890-200104270-00014. View

18.

Hourcade D . The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem. 2005; 281(4):2128-32. DOI: 10.1074/jbc.M508928200. View

19.

Roussel J, Moran C, Salvaris E, Nandurkar H, dApice A, Cowan P . Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am J Transplant. 2008; 8(6):1101-12. DOI: 10.1111/j.1600-6143.2008.02210.x. View

20.

Tai J, Sun H, Liu W, Melling C, Hasilo C, White D . Isolating human islets of Langerhans causes loss of decay accelerating factor (CD55) on beta-cells. Cell Transplant. 2009; 17(12):1349-59. DOI: 10.3727/096368908787648092. View